Correction to 'Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma'

Autor:	Jennifer Willis, Devnandan Chatterjee, Elisabeth Willard, Gareth Williams, Zarin Brown, Duncan Shaw, Ryan West, Edward Charles Hall, David Andrew Sandham, Bindi Sohal, Julia Hatto, Steven J. Charlton, Lucy Barker, Gerald Dubois, Janet Maas, Jodie Manini, Rowan Stringer, Nicholas Duggan, Catherine Ritchie, David C. Budd, Katharine L. Turner, Brian Cox, Catherine Leblanc, Lyndon Nigel Brown, Simon J. Watson, David A. Sykes, Matthew Thomas, Darren Riddy, Rachael Profit
Rok vydání:	2017
Předmět:	medicine.drug_class business.industry Organic Chemistry Drug Discovery medicine Fevipiprant Pharmacology Receptor antagonist medicine.disease business Biochemistry NVP-QAW039 Asthma
Zdroj:	ACS Medicinal Chemistry Letters. 8:987-987
ISSN:	1948-5875
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::938165c3ed79370061b1dfa60d8a65e1 https://doi.org/10.1021/acsmedchemlett.7b00353 Zobrazit plný text záznamu